Blog Category

Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupi...

March 23rd, 2020

New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress...

February 14th, 2020

Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn C...

January 31st, 2020

Helsinn Group Grants Exclusive Licensing Rights to Berlin-Chemie AG, a company o...

January 27th, 2020

Berlin-Chemie AG has been granted exclusive rights to import, distribute, promote, market and sell AKYNZEO® and ONICIT® (ALOXI®) in Russia and CIS reg...

Lyfebulb and Helsinn Announce 11 Finalists for the Third Annual Lyfebulb-Helsinn...

January 14th, 2020

The Award recognizes Patient Entrepreneurs demonstrating outstanding innovations which advance solutions in the prevention, management or care of canc...

Helsinn appoints Eric Cornut and Lonnie Moulder to the Board of Directors

January 13th, 2020